Article info
Basic and translational research
Extended report
Loss of phosphatase and tensin homolog (PTEN) in myeloid cells controls inflammatory bone destruction by regulating the osteoclastogenic potential of myeloid cells
- Correspondence to Dr Kurt Redlich, Division of Rheumatology, Internal Medicine III, Medical University of Vienna, Währinger Gürtel 18-20, Vienna 1090, Austria; kurt.redlich{at}meduniwien.ac.at Gernot Schabbauer, Center for Biomolecular Medicine and Pharmacology, Medical University Vienna. A-1090 Vienna, Austria; gernot.schabbauer@meduniwien.ac.at
Citation
Loss of phosphatase and tensin homolog (PTEN) in myeloid cells controls inflammatory bone destruction by regulating the osteoclastogenic potential of myeloid cells
Publication history
- Received February 18, 2013
- Revised August 21, 2013
- Accepted September 8, 2013
- First published September 27, 2013.
Online issue publication
March 11, 2024
Article Versions
- Previous version (11 March 2024).
- Previous version (11 March 2024).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data supplement 1 - Online figures
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions